Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 231

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 231
---
 to
issue to the Representative, upon the consummation of this offering, warrants to purchase up to an aggregate amount of Ordinary
Shares equal to an aggregate of up to (representing 5.0% of
the Ordinary Shares sold in this offering, including any Ordinary Shares sold upon exercise of the Representative’s
over-allotment option), or the Representative’s Warrants. The Representative’s Warrants are exercisable at a per share
price equal to $ (representing 125.0% of the public offering price per share in this offering). The Representative’s Warrants
are exercisable at any time and from time to time, in whole or in part, during the four and one-half (4.5) year period commencing
180 days from the commencement of sales of the securities in this offering. The Representatives Warrants will provide for
registration rights (including a one-time demand registration right and unlimited piggyback rights) and customary anti-dilution
provisions (for stock dividends and splits and recapitalizations) consistent with FINRA Rule 5110, and further, the number of shares
underlying the Representative’s Warrants shall be reduced if necessary to comply with FINRA rules or regulations.

<div align='center'>134</div>

The Representative’s
Warrants are deemed underwriter compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1)(A).
The Representative (or permitted assignees under Rule 5110(e)(1)(A)) will not sell, transfer, assign, pledge, or hypothecate these warrants
or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that
would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from commencement
of sales in this offering. In addition, the Representative’s Warrants provide for registration rights upon request, in certain cases.
The one-time demand registration right provided will not be greater than five years from the commencement of sales of this offering in
compliance with FINRA Rule 5110(g)(8)(C). The piggyback registration right provided will not be greater than seven years from the commencement
of sales of this offering in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the
securities issuable on exercise of the Representative’s Warrants